+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anti-inflammatory Drugs for Dental Market by Drug Class (Corticosteroids, Nonsteroidal Anti-Inflammatory Drugs), Route of Administration (Injectable, Oral, Topical), Dosage Form, Distribution Channel, End User, Application - Global Forecast 2025-2030- Product Image
Anti-inflammatory Drugs for Dental Market by Drug Class (Corticosteroids, Nonsteroidal Anti-Inflammatory Drugs), Route of Administration (Injectable, Oral, Topical), Dosage Form, Distribution Channel, End User, Application - Global Forecast 2025-2030- Product Image
New

Anti-inflammatory Drugs for Dental Market by Drug Class (Corticosteroids, Nonsteroidal Anti-Inflammatory Drugs), Route of Administration (Injectable, Oral, Topical), Dosage Form, Distribution Channel, End User, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6120385
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Anti-inflammatory drugs have become essential tools in modern dental practice, shaping both clinical protocols and patient satisfaction. As dental procedures become increasingly sophisticated, managing inflammatory responses is paramount to reduce discomfort, accelerate recovery, and minimize complications. In recent years, evolving formulations and delivery modes have broadened treatment options beyond traditional nonsteroidal anti-inflammatory drugs, while corticosteroids have solidified their role in targeted inflammatory control. Leading clinicians and researchers are now redefining best practices, emphasizing personalized regimens that align drug selection with specific procedural needs and patient profiles.

Moreover, patient expectations for rapid pain relief and minimal side effects are driving innovation across the pharmaceutical value chain. Collaborative efforts among formulation scientists, dental specialists, and regulatory bodies have resulted in novel dosage formats designed to optimize local drug concentration at the site of inflammation. These developments underscore the importance of understanding the mechanisms of action and pharmacokinetic properties of each therapeutic option. Cognizant of these trends, stakeholders are seeking comprehensive insights to navigate an increasingly complex landscape of therapies, ensuring both clinical efficacy and cost-effectiveness in dental pain management.

How Breakthrough Drug Delivery Innovations and Digital Dentistry Are Revolutionizing Anti-Inflammatory Care in Dental Procedures

The landscape of anti-inflammatory dental therapies is undergoing a profound transformation driven by advances in drug delivery, precision medicine, and patient-centric care models. Technological innovations in nanoparticle carriers and bioadhesive gels are enabling sustained-release profiles that maintain therapeutic concentrations at sites of periodontal pain longer than ever before. These breakthroughs are complemented by digital dentistry trends, where data analytics and patient monitoring platforms inform individualized dosing strategies, reducing the risk of systemic exposure and adverse events.

Simultaneously, the integration of artificial intelligence in clinical decision support systems is streamlining drug selection, dosage optimization, and outcome prediction. Clinicians can now leverage predictive models that factor in genetic predispositions, comorbidities, and procedural specifics, thus aligning anti-inflammatory protocols with each patient’s unique profile. These cumulative shifts are not only redefining the standard of care but also amplifying the demand for targeted formulations that deliver maximal efficacy with minimal collateral impact. As a result, the market is witnessing a surge in interdisciplinary collaborations aimed at translating cutting-edge research into practice-ready therapies.

Analyzing the Ripple Effects of Newly Enacted 2025 U.S. Tariff Policies on the Sourcing and Availability of Dental Anti-Inflammatory Therapies

The imposition of updated U.S. tariff policies in 2025 has exerted a tangible influence on the supply chains underpinning anti-inflammatory drug availability for dental applications. Increased duties on imported active pharmaceutical ingredients and specialty excipients have prompted many manufacturers to pivot toward localized production or vertically integrated operations to contain costs. In turn, this realignment has accelerated domestic capacity expansions and fostered strategic partnerships between drugmakers and contract development and manufacturing organizations.

Furthermore, regulatory stakeholders have responded by streamlining approval pathways for domestically sourced intermediates, thus mitigating potential disruptions. However, these policy shifts have also triggered price recalibrations, compelling end users to reassess procurement strategies and inventory planning. Dental practices, distributors, and pharmacy networks are increasingly diversifying supplier portfolios to ensure continuity of care and to safeguard against supply shortages. Consequently, the tariff-driven environment is catalyzing a transformative recalibration of sourcing paradigms across the entire value chain.

Decoding Intricate Market Dynamics Through Integrated Analysis of Drug Classes, Delivery Routes, and Usage Contexts in Dental Care

A nuanced understanding of product categories and administration pathways reveals critical inflection points within the anti-inflammatory dental market. Drug classes bifurcate into corticosteroids, represented by dexamethasone and prednisolone, and nonsteroidal anti-inflammatory drugs, such as ibuprofen, ketoprofen, and naproxen, each possessing distinct pharmacodynamic and safety profiles that inform clinical decisions. These molecules assume varying degrees of prominence across injectable, oral, and topical routes of administration, with each delivery option calibrated to procedural demands and patient preferences.

Additionally, the differential adoption of dosage forms-including gel, injection, mouthwash, and tablet presentations-underscores the importance of formulation science in optimizing local tissue penetration and systemic exposure. On the distribution front, hospital pharmacies, online pharmacies, and retail pharmacies each play a pivotal role in channeling products to end users spanning dental clinics, home care environments, and hospitals. Moreover, the clinical applications for mitigating periodontal pain, controlling postoperative discomfort, and preemptively managing preoperative inflammation illustrate the breadth of therapeutic use cases, each driving tailored research, development, and marketing initiatives.

Unveiling Diverse Regional Adoption Patterns and Market Access Strategies in the Americas, EMEA, and Asia-Pacific Dental Sectors

Geographic nuances shape both adoption patterns and competitive intensity in the anti-inflammatory dental market. Within the Americas, well-established healthcare infrastructures and supportive reimbursement frameworks enable rapid deployment of novel formulations, with key markets prioritizing advanced injectable and gel-based delivery systems for outpatient dental settings. In contrast, the Europe, Middle East & Africa zone exhibits pronounced heterogeneity, as differing regulatory regimes and economic conditions influence the pace of innovation uptake, particularly in oral and topical dosage forms that balance efficacy with affordability.

Meanwhile, markets across Asia-Pacific are characterized by accelerated investments in local pharmaceutical manufacturing and increasing public-private collaborations aimed at addressing rising prevalence of periodontal disorders. This region’s embrace of digital health platforms further complements the rollout of remote consultation models, which often rely on easily administered dosage forms like mouthwash and tablets. Collectively, these regional currents underscore the necessity for manufacturers to adopt differentiated go-to-market strategies that respond to distinct regulatory landscapes, distribution networks, and patient expectations.

How Leading Pharmaceutical Entities Are Innovating and Partnering to Strengthen Their Competitive Edge in Dental Anti-Inflammatory Offerings

Leading pharmaceutical and specialty companies are orchestrating targeted initiatives to bolster their positions within the dental anti-inflammatory arena. Industry stalwarts are investing heavily in formulation improvements, exemplified by partnerships that blend local expertise with global research capabilities to accelerate product pipeline progression. Concurrently, emerging biotech firms are securing strategic alliances to commercialize novel sustained-release platforms, seeking to differentiate through proprietary delivery technologies.

On the competitive front, manufacturers are expanding their reach via multi-channel distribution agreements, integrating e-commerce platforms to enhance accessibility while maintaining traditional relationships with professional dental networks. Furthermore, a rising emphasis on real-world evidence generation is driving companies to collaborate with academic and clinical institutions to document efficacy and safety in diverse patient cohorts. Collectively, these strategic endeavors underscore a market in which scale, innovation, and evidence-based positioning coalesce to define leadership.

Strategic Imperatives and Partnership Approaches to Elevate Market Presence and Success in Anti-Inflammatory Dental Therapies

Industry leaders seeking to capitalize on emerging opportunities should prioritize investment in localized manufacturing capabilities to mitigate geopolitical and tariff-related risks. By forging joint ventures with regional stakeholders, organizations can secure reliable ingredient pipelines while benefiting from favorable regulatory incentives. Additionally, expanding into digital therapeutics and integrating patient monitoring solutions can enhance value propositions, fostering stronger engagement with dental professionals and end users alike.

Furthermore, companies should pursue collaborative research efforts with academic institutions to generate robust real-world data, thereby substantiating product differentiation claims. Targeted outreach to hospital pharmacy decision-makers and digital marketing initiatives aimed at online pharmacy users will likewise be critical in maximizing market penetration. Finally, a concerted focus on adapting dosage forms to meet evolving patient expectations-such as user-friendly mouthwash formulations and bioadhesive gels-will position organizations to capture significant share in both clinical and home care settings.

A Rigorous Multi-Source Research Framework Leveraging Expert Interviews, Clinical Evidence, and Regulatory Analyses to Illuminate Market Trends

This analysis is grounded in a multi-tiered methodology that bridges primary and secondary research. Information was culled from peer-reviewed journals, regulatory filings, industry white papers, and public domain databases. Supplementing desk research, in-depth interviews were conducted with key opinion leaders, including practicing dentists, formulation scientists, and procurement specialists across major geographic markets.

Quantitative data were validated through triangulation, reconciling insights from supplier financial reports, clinical trial registries, and distribution channel disclosures. Qualitative assessments were informed by expert roundtables and advisory panels, providing nuanced perspectives on emerging formulation trends and market access dynamics. The research framework ensures a holistic synthesis of technical, clinical, and commercial viewpoints, delivering actionable intelligence without reliance on proprietary forecasts or market sizing.

Synthesizing Clinical Innovations, Supply Chain Evolutions, and Regional Nuances to Chart the Future of Dental Anti-Inflammatory Solutions

In summary, the field of anti-inflammatory drugs in dental care stands at an inflection point, defined by advanced delivery systems, data-driven personalization, and evolving supply chain configurations. Emerging tariff policies have reshaped sourcing strategies, while regional market heterogeneity demands tailored commercialization approaches. Drug classes ranging from dexamethasone and prednisolone to widely used NSAIDs like ibuprofen and naproxen each offer distinct clinical benefits that intersect with varied routes and dosage forms to address specific procedural and patient needs.

As manufacturers deepen their focus on real-world evidence and digital integration, the competitive arena will continue to intensify. Stakeholders equipped with comprehensive, up-to-date intelligence on regulatory landscapes, distribution channels, and patient preferences will be best positioned to drive innovation, optimize operations, and secure leadership in this dynamic segment of dental therapeutics.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Drug Class
    • Corticosteroids
      • Dexamethasone
      • Prednisolone
    • Nonsteroidal Anti-Inflammatory Drugs
      • Ibuprofen
      • Ketoprofen
      • Naproxen
  • Route Of Administration
    • Injectable
    • Oral
    • Topical
  • Dosage Form
    • Gel
    • Injection
    • Mouthwash
    • Tablet
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
  • End User
    • Dental Clinics
    • Home Care
    • Hospitals
  • Application
    • Periodontal Pain
    • Postoperative Pain
    • Preoperative Pain
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Johnson & Johnson
  • Pfizer Inc.
  • Reckitt Benckiser Group PLC
  • Bayer AG
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sandoz International GmbH

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of localized corticosteroid injections for targeted dental inflammation relief
5.2. Development of non-opioid NSAID combinations to reduce post-procedural pain in dental surgeries
5.3. Surge in interest around oral dissolvable anti-inflammatories for improved patient compliance
5.4. Integration of AI-driven diagnostics to personalize anti-inflammatory regimens in periodontal care
5.5. Growth of natural and herbal anti-inflammatory formulations as alternatives to synthetic drugs
5.6. Regulatory shifts accelerating approval of novel anti-inflammatory biologics for endodontic applications
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Anti-inflammatory Drugs for Dental Market, by Drug Class
8.1. Introduction
8.2. Corticosteroids
8.2.1. Dexamethasone
8.2.2. Prednisolone
8.3. Nonsteroidal Anti-Inflammatory Drugs
8.3.1. Ibuprofen
8.3.2. Ketoprofen
8.3.3. Naproxen
9. Anti-inflammatory Drugs for Dental Market, by Route of Administration
9.1. Introduction
9.2. Injectable
9.3. Oral
9.4. Topical
10. Anti-inflammatory Drugs for Dental Market, by Dosage Form
10.1. Introduction
10.2. Gel
10.3. Injection
10.4. Mouthwash
10.5. Tablet
11. Anti-inflammatory Drugs for Dental Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Anti-inflammatory Drugs for Dental Market, by End User
12.1. Introduction
12.2. Dental Clinics
12.3. Home Care
12.4. Hospitals
13. Anti-inflammatory Drugs for Dental Market, by Application
13.1. Introduction
13.2. Periodontal Pain
13.3. Postoperative Pain
13.4. Preoperative Pain
14. Americas Anti-inflammatory Drugs for Dental Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Anti-inflammatory Drugs for Dental Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Anti-inflammatory Drugs for Dental Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Johnson & Johnson
17.3.2. Pfizer Inc.
17.3.3. Reckitt Benckiser Group PLC
17.3.4. Bayer AG
17.3.5. GlaxoSmithKline plc
17.3.6. Sanofi S.A.
17.3.7. Novartis AG
17.3.8. Teva Pharmaceutical Industries Ltd.
17.3.9. Viatris Inc.
17.3.10. Sandoz International GmbH
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET: RESEARCHAI
FIGURE 28. ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET: RESEARCHSTATISTICS
FIGURE 29. ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET: RESEARCHCONTACTS
FIGURE 30. ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY PREDNISOLONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY PREDNISOLONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY IBUPROFEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY IBUPROFEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY KETOPROFEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY KETOPROFEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NAPROXEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NAPROXEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY GEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY MOUTHWASH, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY MOUTHWASH, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY PERIODONTAL PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY PERIODONTAL PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY POSTOPERATIVE PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY POSTOPERATIVE PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY PREOPERATIVE PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY PREOPERATIVE PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 107. CANADA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 108. CANADA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 109. CANADA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 110. CANADA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 111. CANADA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 112. CANADA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 113. CANADA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. CANADA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. CANADA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 116. CANADA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 117. CANADA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. CANADA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. CANADA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. CANADA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. CANADA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. MEXICO ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 124. MEXICO ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 125. MEXICO ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 126. MEXICO ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 127. MEXICO ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 128. MEXICO ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 129. MEXICO ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 130. MEXICO ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 131. MEXICO ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 132. MEXICO ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 133. MEXICO ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. MEXICO ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. MEXICO ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. MEXICO ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. MEXICO ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. MEXICO ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. GERMANY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 206. GERMANY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 207. GERMANY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 208. GERMANY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 209. GERMANY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 210. GERMANY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 211. GERMANY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 212. GERMANY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 213. GERMANY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 214. GERMANY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 215. GERMANY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. GERMANY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. GERMANY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. GERMANY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. GERMANY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. GERMANY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. FRANCE ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 222. FRANCE ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 223. FRANCE ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 224. FRANCE ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 225. FRANCE ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 226. FRANCE ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 227. FRANCE ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 228. FRANCE ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 229. FRANCE ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 230. FRANCE ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 231. FRANCE ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. FRANCE ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. FRANCE ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. FRANCE ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. FRANCE ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. FRANCE ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. ITALY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 254. ITALY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 255. ITALY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 256. ITALY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 257. ITALY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 258. ITALY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 259. ITALY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 260. ITALY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 261. ITALY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 262. ITALY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 263. ITALY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. ITALY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. ITALY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. ITALY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. ITALY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. ITALY ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. SPAIN ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 270. SPAIN ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 271. SPAIN ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILLION)
TABLE 272. SPAIN ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2025-2030 (USD MILLION)
TABLE 273. SPAIN ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 274. SPAIN ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 275. SPAIN ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. SPAIN ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. SPAIN ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 278. SPAIN ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 279. SPAIN ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. SPAIN ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. SPAIN ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. SPAIN ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. SPAIN ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. SPAIN ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES ANTI-INFLAMMATORY DRUGS FOR DENTAL MARKET SIZE, BY CORTICOSTEROIDS, 2018-2024 (USD MILL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Anti-inflammatory Drugs for Dental market report include:
  • Johnson & Johnson
  • Pfizer Inc.
  • Reckitt Benckiser Group PLC
  • Bayer AG
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Sandoz International GmbH

Related Topics

Related Reports

Dental Anti-inflammatory Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Dental Anti-inflammatory Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Gout Medications Market by Drug Class (Colchicine, Nonsteroidal Anti-Inflammatory Drugs, Recombinant Uricase), Route of Administration (Intravenous, Oral, Subcutaneous), Distribution Channel, Dosage Form, End User - Global Forecast 2025-2030 - Product Image

Gout Medications Market by Drug Class (Colchicine, Nonsteroidal Anti-Inflammatory Drugs, Recombinant Uricase), Route of Administration (Intravenous, Oral, Subcutaneous), Distribution Channel, Dosage Form, End User - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Gout Therapeutics Market by Route Of Administration (Injectable, Oral), Therapy Line (First Line, Second Line, Third Line), Drug Class, Distribution Channel - Global Forecast 2025-2030 - Product Image

Gout Therapeutics Market by Route Of Administration (Injectable, Oral), Therapy Line (First Line, Second Line, Third Line), Drug Class, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Anti-Inflammatory Therapeutics Market by Therapeutic Class, Mechanism Of Action, Route Of Administration, Distribution Channel, Indication, End User - Global Forecast 2025-2030 - Product Image

Anti-Inflammatory Therapeutics Market by Therapeutic Class, Mechanism Of Action, Route Of Administration, Distribution Channel, Indication, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Clinical Dental Pharmacology. Edition No. 1 - Product Image

Clinical Dental Pharmacology. Edition No. 1

  • Book
  • 208 Pages
Copyright © 2002-2025 Research and Markets. All Rights Reserved.